⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Replit ouvre son premier bureau international à Londres
prnewswire.com
MSFT
GOOG
ADBE
ACN
V
Z
NVDA
AMZN
META
IBM
ORCL
CRM
INTC
AMD
QCOM
MU
AMAT
ASML
TXN
ADI
NXPI
LRCX
KLAC
CDNS
SNPS
MCHP
ON
WDC
SE
PLTR
UPST
COIN
BNTX
MRNA
GILD
BMY
AMGN
REGN
LLY
BIIB
VRTX
AZN
XOM
CVX
SHEL
BABA
JD
NTES
PDD
BIDU
MELI
NIO
LI
XPEV
RIVN
TSLA
PLUG
FCEL
SPCE
CRSP
EDIT
NTLA
ALGN
EXAS
TDOC
ROKU
PYPL
HOOD
MARA
RIOT
Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Contact Levi & Korsinsky Before September 14, 2026 to Join Class Action
accessnewswire.com
REGN
Pomerantz LLP Shares Class Action Details With Shareholders in Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Did You Lose Money on Regeneron Pharmaceuticals, Inc. (REGN)? Levi & Korsinsky Urges Investors to Act Before September 14, 2026
accessnewswire.com
REGN
REGN SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regeneron (REGN) Investors of Securities Class Action Lawsuit Deadline on September 14, 2026 Ready to Announce with Confidence?
newsfilecorp.com
REGN
REGN 1-WEEK DEADLINE ALERT: Regeneron Pharmaceuticals, Inc. Investors Alerted to September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit
prnewswire.com
REGN
Levi & Korsinsky Urges Regeneron Pharmaceuticals, Inc. (REGN) Shareholders to Act Before Lead Plaintiff Deadline September 14, 2026
accessnewswire.com
REGN
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com
REGN
Class Action Alert: Levi & Korsinsky Reminds Regeneron (REGN) Investors of September 14, 2026 Deadline
accessnewswire.com
REGN
Fc Fusion Therapeutics Market Assessment 2026-2035: Patent Activity Continues to Expand Among Commercial Drug Developers and Academic Research Institutions
globenewswire.com
AMGN
REGN